Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Registry Study on the Risk Factors of Interstitial Pneumonia in Lymphoma Patients Treated With Liposomal Doxorubicin

NCT04069845 is registered in ClinicalTrials.gov with Ruijin Hospital as lead sponsor.

NCT NCT04069845
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04069845 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Registry Study on the Risk Factors of Interstitial Pneumonia in Lymphoma Patients Treated With Liposomal Doxorubicin
Lead sponsor
Ruijin Hospital
Phase
Observational
Overall status
Unknown status
Start date
August 1, 2019
Completion date
August 30, 2021
Enrollment
2,000 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

lymphoma